John W. Higuchi insider trades: Lipocine (LPCN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | LPCN | ↑ Buy | 25,007 | $2.20 | $55K | Direct | Oct 1, 2026 (1d) |
| Sep 28, 2026 | LPCN | ↑ Buy | 12,561 | $2.16 | $27K | Direct | Sep 30, 2026 (2d) |
| Apr 7, 2026 | LPCN | ↑ Buy | 40,000 | $2.03 | $81K | Direct | Apr 7, 2026 (0d) |
| Apr 6, 2026 | LPCN | ↑ Buy | 123,000 | $2.05 | $252K | Direct | Apr 6, 2026 (0d) |
| Dec 31, 2020 | LPCN | ↓ Sell | 6,700 | $1.35 | $9K | Direct | Jan 4, 2021 (4d) |
| Mar 17, 2020 | LPCN | ↑ Buy | 220,000 | $0.32 | $70K | Direct | Mar 18, 2020 (1d) |
| Sep 30, 2015 | LPCN | ↑ Buy | 5,000 | $12.68 | $63K | Direct | Oct 2, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LPCN insiders
Open-market trades in the last 12 months
About John W. Higuchi's insider trades
John W. Higuchi is a director at Lipocine (LPCN). Since Sep 30, 2015, John has reported 6 open-market purchases worth $548K and 1 sale worth $9K on SEC Form 4. In the last 12 months: 4 buys ($416K).
Their filings also include grants and awards (13 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LPCN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.